Though there has been some rudimentary research work indicating that the GLP-1 receptor agonists can indirectly provide mood-enhancing effects by regulating the dopamine reward system, lessening inflammatory responses, or improving metabolic status, adverse events that have been observed in real life studies and case reports can suggest that their action at the central nervous system is more complicated [11, 16, 17]
This aggregation may lead to structural changes such as fusion of neighboring or encapsulated liposomes together [428]
AOD 9604 targets only peripheral fat metabolism without affecting the GH axis, making it relevant to investigational protocols in which isolated lipolytic activity is the objective and systemic GH effects are not required
These symptoms do not always mean B12 deficiency, but they warrant proper evaluation if they persist
The total drug exposure over the week is the same, which means the metabolic effects should be equivalent